Nova Leap Health Corp
(NLH.VN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 234 | 308 | 344 | 374 | 331 |
| Income taxes - deferred | 123 | -317 | 955 | 60 | -211 |
| Accounts receivable | 123 | 283 | 162 | -94 | 66 |
| Accounts payable and accrued liabilities | 44 | -99 | 190 | -303 | 145 |
| Other Working Capital | 119 | -81 | 398 | -779 | 352 |
| Other Operating Activity | -348 | -286 | -522 | 60 | -314 |
| Operating Cash Flow | $294 | $-193 | $1,528 | $-682 | $368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -9 | -10 | -16 | -37 |
| Other Investing Activity | 5 | 0 | 0 | 0 | 15 |
| Investing Cash Flow | $-23 | $-9 | $-10 | $-16 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -624 | -639 | -1,485 | -409 | -403 |
| Common Stock Issued | N/A | 0 | 1,788 | 0 | N/A |
| Other Financing Activity | -26 | -107 | -28 | -86 | -44 |
| Financing Cash Flow | $-650 | $-746 | $275 | $-495 | $-447 |
| Exchange Rate Effect | 1 | 13 | -34 | -4 | 14 |
| Beginning Cash Position | 1,273 | 2,207 | 449 | 1,647 | 1,733 |
| End Cash Position | 894 | 1,273 | 2,207 | 449 | 1,647 |
| Net Cash Flow | $-379 | $-948 | $1,793 | $-1,194 | $-100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 294 | -193 | 1,528 | -682 | 368 |
| Capital Expenditure | -28 | -9 | -10 | -16 | -37 |
| Free Cash Flow | 266 | -202 | 1,518 | -698 | 332 |